Daxor Corp
DXR- Exchange
- Nasdaq
- SEC CIK
- 0000027367
No open-market purchases or sales by Daxor Corp insiders were filed in the last 90 days; 15 institutions reported holding it in 13F filings for Q2 2026, worth $4.33M in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Daxor Corp insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Daxor Corp, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Jefferies John | Chief Medical Officer | 26,008 | Sep 1, 2026 | 3 |
| Michel Robert J | Chief Financial Officer | 33,050 | Jun 25, 2026 | 3 |
| Feldschuh Michael Richard | Chief Executive Officer | 243,694 | Jun 25, 2026 | 2 |
| Feuer Edward | Director | 1,000 | Jun 25, 2026 | 1 |
| Feldschuh Jonathan Adam | Chief Scientific Officer | 78,908 | Jun 25, 2026 | 2 |
| Cremisi Henry D. | Director | – | Jun 25, 2026 | 1 |
| Goudie Joy S. | Director | 300 | Jun 25, 2026 | 1 |
| DesRosiers Caleb | Director | 3,157 | Jun 25, 2026 | 1 |
| Estate of Joseph Feldschuh | 10% Owner | 2,549,455 | Sep 20, 2023 | 0 |
| Lombard James A | Director | – | Jul 13, 2023 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Apr 10, 2026 (view filing) | Apr 8 | 2 days | Feldschuh Michael RichardChief Executive Officer | PPurchaseDaxor Common Stock | +1.00K | $9.07 | +$9.07K | +0.5%213.7K after | |
| Mar 31, 2026 (view filing) | Mar 31 | Same day | Michel Robert JChief Financial Officer | PPurchaseDaxor Common Stock | +1.00K | $9.90 | +$9.90K | +5.0%21.1K after | |
| Mar 24, 2026 (view filing) | Mar 20 | 4 days | Jefferies JohnChief Medical Officer | PPurchaseDaxor Common Stock | +5.94K | $0.00 | $0 | +33.7%23.6K after | 2 lots |
| Dec 11, 2025 (view filing) | Dec 9 | 2 days | Michel Robert JChief Financial Officer | PPurchaseDaxor Common Stock | +3.00K | $0.00 | $0 | +17.6%20.1K after | |
| Dec 11, 2025 (view filing) | Dec 9 | 2 days | Feldschuh Jonathan AdamChief Scientific Officer | PPurchaseDaxor Common Stock | +18.0K | $0.00 | $0 | +50.1%53.9K after | |
| Nov 14, 2025 (view filing) | Nov 12 | 2 days | Jefferies JohnChief Medical Officer | PPurchaseDaxor Common Stock | +2.34K | $0.00 | $0 | +15.3%17.6K after | |
| Apr 7, 2025 (view filing) | Apr 4 | 3 days | Feldschuh Michael RichardChief Executive Officer | PPurchaseDaxor Common Stock | +2.06K | $7.89 | +$16.3K | +1.0%212.7K after | |
| Mar 27, 2025 (view filing) | Mar 26, 2024 | 366 daysLate | Feldschuh Michael RichardChief Executive Office | PPurchaseDaxor Common Stock | +1.00K | $8.13 | +$8.13K | +0.5%210.6K after | |
| Mar 20, 2025 (view filing) | Mar 10, 2024 | 375 days | Feldschuh Michael RichardChief Executive Officer | PPurchaseDaxor Common Stock | +1.49K | $7.72 | +$11.5K | +0.7%209.0K after | Amended |
| Mar 20, 2025 (view filing) | Mar 19, 2024 | 366 daysLate | Feldschuh Michael RichardChief Executive Officer | PPurchaseDaxor Common Stock | +647 | $8.15 | +$5.27K | +0.3%209.6K after | |
| Mar 11, 2025 (view filing) | Mar 10 | 1 day | Michel Robert JChief Financial Officer | PPurchaseDaxor Common Stock | +1.00K | $8.00 | +$8.00K | +6.2%17.1K after | |
| Dec 10, 2024 (view filing) | Dec 6 | 4 days | Feldschuh Jonathan AdamChief Scientific Officer | PPurchaseDaxor Common Stock | +32.0K | $0.00 | $0 | +818.8%35.9K after | |
| Dec 10, 2024 (view filing) | Dec 6 | 4 days | Feldschuh Michael RichardChief Executive Officer | PPurchaseDaxor Common Stock | +45.0K | $0.00 | $0 | +27.7%207.5K after | |
| Dec 10, 2024 (view filing) | Mar 27, 2023 | 624 daysLate | Michel Robert JChief Financial Officer | PPurchaseDaxor Common Stock | +4.75K | $0.00 | $0 | +46.1%15.1K after | |
| Mar 27, 2024 (view filing) | Mar 27 | Same day | Michel Robert JChief Financial Officer | PPurchaseDaxor Common Stock | +750 | $8.70 | +$6.53K | +7.1%11.3K after | |
| Mar 6, 2024 (view filing) | Mar 4 | 2 days | Feuer EdwardDirector | PPurchaseDaxor Common Stock | +1.00K | $7.21 | +$7.21K | New position1.00K after | |
| Dec 6, 2023 (view filing) | Dec 6 | Same day | Michel Robert JChief Financial Officer | PPurchaseDaxor Common Stock | +120 | $7.75 | +$930 | +1.2%10.6K after | |
| Dec 1, 2023 (view filing) | Dec 1 | Same day | Michel Robert JChief Financial Officer | PPurchaseDaxor Common Stock | +180 | $7.75 | +$1.40K | +1.8%10.4K after | |
| Dec 1, 2023 (view filing) | Dec 1 | Same day | Feldschuh Michael RichardChief Executive Officer | PPurchaseDaxor Common Stock | +800 | $7.80 | +$6.24K | +0.5%162.5K after | |
| Nov 27, 2023 (view filing) | Nov 24 | 3 days | Michel Robert JChief Financial Officer | PPurchaseDaxor Common Stock | +500 | $7.94 | +$3.97K | +5.1%10.3K after | |
| Nov 13, 2023 (view filing) | Nov 9-10 | 4 days | Feldschuh Michael RichardCHIEF EXECUTIVE OFFICER | PPurchaseDaxor Common Stock | +1.40K | $7.84 | +$11.0K | +0.9%161.6K after | 2 lots |
| Oct 16, 2023 (view filing) | Oct 13 | 3 days | Michel Robert JChief Financial Officer | PPurchaseDaxor Common Stock | +500 | $9.02 | +$4.51K | +6.9%7.75K after | |
| May 25, 2023 (view filing) | May 24 | 1 day | Feldschuh Michael RichardCEO & President | PPurchase | +2.00K | $9.75 | +$19.5K | +1.3%160.2K after | |
| May 25, 2023 (view filing) | May 24 | 1 day | Goudie Joy S.Director | PPurchase | +300 | $9.75 | +$2.92K | New position300 after | |
| Nov 18, 2022 (view filing) | Nov 17 | 1 day | DesRosiers CalebDirector | PPurchaseDaxor Common Stock | +3.16K | $9.50 | +$30.0K | New position3.16K after | |
| Nov 18, 2022 (view filing) | Nov 18 | Same day | Michel Robert JChief Financial Officer | PPurchaseDaxor Common Stock | +1.00K | $10.00 | +$10.0K | +16.0%7.25K after |